Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for AvePoint (AVPT) over the last 7 years, with Q3 2025 value amounting to $471.6 million.

  • AvePoint's Cash & Equivalents rose 8880.48% to $471.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.6 million, marking a year-over-year increase of 8880.48%. This contributed to the annual value of $290.7 million for FY2024, which is 3027.98% up from last year.
  • According to the latest figures from Q3 2025, AvePoint's Cash & Equivalents is $471.6 million, which was up 8880.48% from $429.8 million recorded in Q2 2025.
  • AvePoint's 5-year Cash & Equivalents high stood at $471.6 million for Q3 2025, and its period low was $139492.0 during Q1 2021.
  • Its 5-year average for Cash & Equivalents is $222.7 million, with a median of $227.0 million in 2024.
  • In the last 5 years, AvePoint's Cash & Equivalents tumbled by 8166.14% in 2021 and then soared by 5636488.69% in 2022.
  • Over the past 5 years, AvePoint's Cash & Equivalents (Quarter) stood at $268.2 million in 2021, then fell by 15.3% to $227.2 million in 2022, then decreased by 1.77% to $223.2 million in 2023, then surged by 30.28% to $290.7 million in 2024, then soared by 62.22% to $471.6 million in 2025.
  • Its Cash & Equivalents stands at $471.6 million for Q3 2025, versus $429.8 million for Q2 2025 and $351.5 million for Q1 2025.